Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects

Ottoboni, T; Lauw, M; Keller, MR; Cravets, M; Manhard, K; Clendeninn, N; Quart, B

Ottoboni, T (reprint author), Heron Therapeut Inc, Pharmaceut & Translat Sci, Campus Point Court,Suite 200, San Diego, CA 92121 USA.

FUTURE ONCOLOGY, 2018; 14 (27): 2849

Abstract

Aim: Evaluate safety of HTX-019, a novel polysorbate 80- and synthetic surfactant-free intravenous formulation of neurokinin 1 receptor antagonist apr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索